Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.
Published in Dermatology

Journal Scan / Research · November 11, 2023

Safety of Biologic Therapy in Combination With Methotrexate in Patients With Moderate to Severe Psoriasis

The British Journal of Dermatology


Additional Info

The British Journal of Dermatology
Safety of biologic therapy in combination with methotrexate in moderate to severe psoriasis: a cohort study from the BIOBADADERM registry
Br J Dermatol 2023 Oct 17;[EPub Ahead of Print], JJ Lluch-Galcerá, JM Carrascosa, A González-Quesada, R Rivera-Díaz, A Sahuquillo-Torralba, M Llamas-Velasco, FJ Gómez-García, E Herrera-Acosta, P de la Cueva, O Baniandrés-Rodríguez, JL Lopez-Estebaranz, I Belinchón, M Ferrán, A Mateu, L Rodríguez, J Riera-Monroig, MT Abalde-Pintos, G Carretero, C García-Donoso, C Pujol-Marco, E Del Alcázar, C Santamaría-Domínguez, JA Suárez-Pérez, LM Nieto-Benito, DP Ruiz-Genao, L Salgado-Boquete, MÁ Descalzo, I García-Doval

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading